Glycobiology vol 2 no 6 pp. 523-528, 1992
© 1992
review-article |
Heparan sulphate in the binding and activation of basic fibroblast growth factor
Departments of Medical Oncology and Clinical Research, Christie Hospital NHS Trust Wilmslow Road, Manchester, M20 9BX, UK
Received on September 18, 1992; accepted on September 21, 1992
Heparan sulphate proteoglycans (HSPGs) are widely distributed in animal tissues, but their most prominent locations are cell surface membranes and basement membranes. Their influence on various fundamental aspects of cell behaviour (e.g. cell adhesion, growth and morphogenesis) are dependent on the specific binding properties of the heparan sulphate (HS) chains. These polysaccharides are complex structures in which N-sulphated glucosamine and ester sulphate groups tend to be clustered in discrete regions of the chain separated by sequences enriched in N-acetylglucosamine residues, but with a low sulphate concentration. The sulphated domains contain the sugar residue sequences for interaction with specific proteins essential for HS function. In this review, we describe the plasma membrane HSPGs and their role in regulating the activity of basic fibroblast growth factor (bFGF).
cell surfaces fibroblast growth factor (FGF) heparan sulphate proteoglycans syndecan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Bloushtain, U. Qimron, A. Bar-Ilan, O. Hershkovitz, R. Gazit, E. Fima{dagger}, M. Korc, I. Vlodavsky, N. V. Bovin, and A. Porgador Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp46 J. Immunol., August 15, 2004; 173(4): 2392 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lai, J. Chien, J. Staub, R. Avula, E. L. Greene, T. A. Matthews, D. I. Smith, S. H. Kaufmann, L. R. Roberts**, and V. Shridhar** Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer J. Biol. Chem., June 13, 2003; 278(25): 23107 - 23117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Sachchidanand, O. Lequin, D. Staunton, B. Mulloy, M. J. Forster, K. Yoshida, and I. D. Campbell Mapping the Heparin-binding Site on the 13-14F3 Fragment of Fibronectin J. Biol. Chem., December 20, 2002; 277(52): 50629 - 50635. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Salek-Ardakani, J. R. Arrand, D. Shaw, and M. Mackett Heparin and heparan sulfate bind interleukin-10 and modulate its activity Blood, September 1, 2000; 96(5): 1879 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. van Kuppevelt, M. A. B. A. Dennissen, W. J. van Venrooij, R. M. A. Hoet, and J. H. Veerkamp Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology. FURTHER EVIDENCE FOR HEPARAN SULFATE HETEROGENEITY IN THE KIDNEY J. Biol. Chem., May 22, 1998; 273(21): 12960 - 12966. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. I. Raats, M. A. H. Bakker, J. van den Born, and J. H. M. Berden Hydroxyl Radicals Depolymerize Glomerular Heparan Sulfate in Vitro and in Experimental Nephrotic Syndrome J. Biol. Chem., October 17, 1997; 272(42): 26734 - 26741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Herr, D. M. Ornitz, R. Sasisekharan, G. Venkataraman, and G. Waksman Heparin-induced Self-association of Fibroblast Growth Factor-2. EVIDENCE FOR TWO OLIGOMERIZATION PROCESSES J. Biol. Chem., June 27, 1997; 272(26): 16382 - 16389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Walz, S McFarlane, Y. Brickman, V Nurcombe, P. Bartlett, and C. Holt Essential role of heparan sulfates in axon navigation and targeting in the developing visual system Development, January 6, 1997; 124(12): 2421 - 2430. [Abstract] [PDF] |
||||
![]() |
M. Maccarana, Y. Sakura, A. Tawada, K. Yoshida, and U. Lindahl Domain Structure of Heparan Sulfates from Bovine Organs J. Biol. Chem., July 26, 1996; 271(30): 17804 - 17810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joseph, M. Ford, C Barth, S Portbury, P. Bartlett, V Nurcombe, and U Greferath A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant Development, January 11, 1996; 122(11): 3443 - 3452. [Abstract] [PDF] |
||||



